Filing Details
- Accession Number:
- 0001437749-25-021577
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-06-30 17:02:34
- Reporting Period:
- 2025-06-26
- Filing Date:
- 2025-06-30
- Accepted Time:
- 2025-06-30 17:02:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1434647 | Zevra Therapeutics Inc. | ZVRA | Pharmaceutical Preparations (2834) | 205894398 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1788524 | Rahsaan Thompson | C/O Zevra Therapeutics, Inc. 1180 Celebration Boulevard, Suite 103 Celebration FL 34747 | Chief Legal & Compliance | No | Yes | No | Yes |
Transaction Summary
| Sold: | 24,000 shares | Avg. Price: $9.21 | Total Value: $221,004.00 |
| Number of Shares After Transactions: | 42,666 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-06-26 | 24,000 | $9.21 | 42,666 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Adoption date of referenced 10b5-1(c) plan is: 03-27-2025
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.11 to $9.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
